Prediction of cognitive decline in early Alzheimer's disease

Lancet

Volumn 352, Issue 9141, 1998, Pages 1678-

  Doraiswamy, P Murali ^a   Charles, H Cecil ^a   Krishnan, K Ranga Rama ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL; MARKER; N ACETYLASPARTIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GLIA CELL; HUMAN; NERVE CELL; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0032556505     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)61449-3     Document Type: Article

References (5)

1. 1 Charles HC, Snyderman T, Ahearn E. Magnetic resonance spectroscopy. In: Krishnan KR, Doraiswamy PM, eds. Brain imaging in clinical psychiatry. New York: Marcel Dekker, 1997: 13-23.
2. 2 Steffens DS. MRI and MRS in dementia. In: Krishnan KR, Doraiswamy PM, eds. Brain imaging in clinical psychiatry. New York: Marcel Dekker, 1997: 503-33.
3. 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains. Exp Brain Res 1995; 102: 503-10.
4. 4 Holshouser BA, Ashwal S, Luh GY, et al. Proton MR spectroscopy after acute central nervous system injury: outcome prediction in neonates, infants, and children. Radiology 1997; 202: 487-96.
5. 5 Charles HC, Lazeyras F, Tupler L, Krishnan KRR. Reproducibility of high spatial resolution proton magnetic resonance spectroscopic imaging in the human brain. Magn Res Med 1996; 35: 606-10.